SRZNW icon

Surrozen Inc Warrant
SRZNW

1 day
5 days
1 month
3 months
6 months
Year to date
1 year
5 years
10 years
 

About: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Employees: 41

0
Funds holding %
of 7,539 funds
Analysts bullish %
Positive news %
Price charts implemented using Lightweight Charts™